Collagen XVI in health and disease

Matrix Biology

Volumn 32, Issue 2, 2013, Pages 64-73

  Grässel, Susanne ^a,b   Bauer, Richard J ^b,c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Centre for Medical Biotechnology   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Carcinogenesis; Collagen XVI; FACIT; Glioblastoma; Integrin; Myofibroblasts; Oral squamous cell carcinoma; Pathophysiology

Indexed keywords

COLLAGEN TYPE 16;

CARCINOGENESIS; CHROMOSOME 1; CROHN DISEASE; DERMOEPIDERMAL JUNCTION; DNA SEQUENCE; DOWN REGULATION; FIBROSIS; GENE EXPRESSION; HUMAN; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

BINDING SITES; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; COLLAGEN; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN BINDING;

EID: 84875810865     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2012.11.001     Document Type: Review

References (86)

1. Akagi A., Tajima S., Ishibashi A., Yamaguchi N., Nagai Y. Expression of type XVI collagen in human skin fibroblasts: enhanced expression in fibrotic skin diseases. J. Invest. Dermatol. 1999, 113:246-250.
2. Akagi A., Tajima S., Ishibashi A., Matsubara Y., Takehana M., Kobayashi S., Yamaguchi N. Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa. J. Invest. Dermatol. 2002, 118:267-274.
3. Amenta P.S., Hadad S., Lee M.T., Barnard N., Li D., Myers J.C. Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast. J. Pathol. 2003, 199:298-308.
4. Aumailley M., Gayraud B. Structure and biological activity of the extracellular matrix. J. Mol. Med. (Berl) 1998, 76:253-265.
5. Baba Y., Iyama K., Honda S., Ishikawa S., Miyanari N., Baba H. Cytoplasmic expression of type VII collagen is related to prognosis in patients with esophageal squamous cell carcinoma. Oncology 2006, 71:221-228.
6. Barr P.J. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 1991, 66:1-3.
7. Bauer R., Ratzinger S., Wales L., Bosserhoff A., Senner V., Grifka J., Grassel S. Inhibition of collagen XVI expression reduces glioma cell invasiveness. Cell. Physiol. Biochem. 2011, 27:217-226.
8. Bockenstedt P., McDonagh J., Handin R.I. Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen. J. Clin. Invest. 1986, 78:551-556.
9. Bruckner P. Suprastructures of extracellular matrices: paradigms of functions controlled by aggregates rather than molecules. Cell Tissue Res. 2010, 339:7-18.
10. Burke J.P., Mulsow J.J., O'Keane C., Docherty N.G., Watson R.W., O'Connell P.R. Fibrogenesis in Crohn's disease. Am. J. Gastroenterol. 2007, 102:439-448.
11. Carter E.M., Raggio C.L. Genetic and orthopedic aspects of collagen disorders. Curr. Opin. Pediatr. 2009, 21:46-54.
12. Cerio R., Griffiths C.E., Cooper K.D., Nickoloff B.J., Headington J.T. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br. J. Dermatol. 1989, 121:421-431.
13. Cleary E.G., Gibson M.A. Elastin-associated microfibrils and microfibrillar proteins. Int. Rev. Connect. Tissue Res. 1983, 10:97-209.
14. Desmouliere A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 1995, 146:56-66.
15. Eble J.A., Kassner A., Niland S., Morgelin M., Grifka J., Grassel S. Collagen XVI harbors an integrin alpha1 beta1 recognition site in its C-terminal domains. J. Biol. Chem. 2006, 281:25745-25756.
16. Exposito J.Y., Valcourt U., Cluzel C., Lethias C. The fibrillar collagen family. Int. J. Mol. Sci. 2010, 11:407-426.
17. Gara S.K., Grumati P., Urciuolo A., Bonaldo P., Kobbe B., Koch M., Paulsson M., Wagener R. Three novel collagen VI chains with high homology to the alpha3 chain. J. Biol. Chem. 2008, 283:10658-10670.
18. Gerecke D.R., Foley J.W., Castagnola P., Gennari M., Dublet B., Cancedda R., Linsenmayer T.F., van der R.M., Olsen B.R., Gordon M.K. Type XIV collagen is encoded by alternative transcripts with distinct 5' regions and is a multidomain protein with homologies to von Willebrand's factor, fibronectin, and other matrix proteins. J. Biol. Chem. 1993, 268:12177-12184.
19. Gordon M.K., Hahn R.A. Collagens. Cell Tissue Res. 2010, 339:247-257.
20. Gordon M.K., Gerecke D.R., Olsen B.R. Type XII collagen: distinct extracellular matrix component discovered by cDNA cloning. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:6040-6044.
21. Grassel S., Timpl R., Tan E.M., Chu M.L. Biosynthesis and processing of type XVI collagen in human fibroblasts and smooth muscle cells. Eur. J. Biochem. 1996, 242:576-584.
22. Grassel S., Tan E.M., Timpl R., Chu M.L. Collagen type XVI expression is modulated by basic fibroblast growth factor and transforming growth factor-beta. FEBS Lett. 1998, 436:197-201.
23. Grassel S., Unsold C., Schacke H., Bruckner-Tuderman L., Bruckner P. Collagen XVI is expressed by human dermal fibroblasts and keratinocytes and is associated with the microfibrillar apparatus in the upper papillary dermis. Matrix Biol. 1999, 18:309-317.
24. Grassel S., Ahmed N., Gottl C., Grifka J. Gene and protein expression profile of naive and osteo-chondrogenically differentiated rat bone marrow-derived mesenchymal progenitor cells. Int. J. Mol. Med. 2009, 23:745-755.
25. Gutman A., Kornblihtt A.R. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:7179-7182.
26. Hansen U., Bruckner P. Macromolecular specificity of collagen fibrillogenesis: fibrils of collagens I and XI contain a heterotypic alloyed core and a collagen I sheath. J. Biol. Chem. 2003, 278:37352-37359.
27. Harburger D.S., Bouaouina M., Calderwood D.A. Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects. J. Biol. Chem. 2009, 284:11485-11497.
28. Hari A., Djohar B., Skutella T., Montazeri S. Neurotrophins and extracellular matrix molecules modulate sensory axon outgrowth. Int. J. Dev. Neurosci. 2004, 22:113-117.
29. Hohenester E., Engel J. Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 2002, 21:115-128.
30. Hubert T., Grimal S., Ratzinger S., Mechaly I., Grassel S., Fichard-Carroll A. Collagen XVI is a neural component of the developing and regenerating dorsal root ganglia extracellular matrix. Matrix Biol. 2007, 26:206-210.
31. Imamura Y., Steiglitz B.M., Greenspan D.S. Bone morphogenetic protein-1 processes the NH2-terminal propeptide, and a furin-like proprotein convertase processes the COOH-terminal propeptide of pro-alpha1(V) collagen. J. Biol. Chem. 1998, 273:27511-27517.
32. Inoguchi K., Yoshioka H., Khaleduzzaman M., Ninomiya Y. The mRNA for alpha 1(XIX) collagen chain, a new member of FACITs, contains a long unusual 3' untranslated region and displays many unique splicing variants. J. Biochem. 1995, 117:137-146.
33. Gibran N.S., Nickoloff B.J., Holbrook K.A. Ontogeny and characterization of factor XIIIa+ cells in developing human skin. Anat. Embryol. Berl 1996, 193(1):35-41.
34. Kassner A., Hansen U., Miosge N., Reinhardt D.P., Aigner T., Bruckner-Tuderman L., Bruckner P., Grassel S. Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded microfibrils. Matrix Biol. 2003, 22:131-143.
35. Kassner A., Tiedemann K., Notbohm H., Ludwig T., Morgelin M., Reinhardt D.P., Chu M.L., Bruckner P., Grassel S. Molecular structure and interaction of recombinant human type XVI collagen. J. Mol. Biol. 2004, 339:835-853.
36. Kaufman L.J., Brangwynne C.P., Kasza K.E., Filippidi E., Gordon V.D., Deisboeck T.S., Weitz D.A. Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns. Biophys. J. 2005, 89:635-650.
37. Kiefer J., Alexander A., Farach-Carson M.C. Type I collagen-mediated changes in gene expression and function of prostate cancer cells. Cancer Treat. Res. 2004, 118:101-124.
38. Lai C.H., Chu M.L. Tissue distribution and developmental expression of type XVI collagen in the mouse. Tissue Cell 1996, 28:155-164.
39. Lai K.K., Shang S., Lohia N., Booth G.C., Masse D.J., Fausto N., Campbell J.S., Beretta L. Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet. 2011, 7:e1002147.
40. Lamberg A., Helaakoski T., Myllyharju J., Peltonen S., Notbohm H., Pihlajaniemi T., Kivirikko K.I. Characterization of human type III collagen expressed in a baculovirus system. Production of a protein with a stable triple helix requires coexpression with the two types of recombinant prolyl 4-hydroxylase subunit. J. Biol. Chem. 1996, 271:11988-11995.
41. Liang Y., Diehn M., Bollen A.W., Israel M.A., Gupta N. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment. J. Neurooncol. 2008, 86:133-141.
42. Maegdefrau U., Bosserhoff A.K. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells. Exp. Mol. Pathol. 2012, 92:74-81.
43. Mayne R., Brewton R.G. New members of the collagen superfamily. Curr. Opin. Cell Biol. 1993, 5:883-890.
44. Mechaly I., Bourane S., Piquemal D., Al Jumaily M., Venteo S., Puech S., Scamps F., Valmier J., Carroll P. Gene profiling during development and after a peripheral nerve traumatism reveals genes specifically induced by injury in dorsal root ganglia. Mol. Cell. Neurosci. 2006, 32:217-229.
45. Mosher D.F. Cross-linking of fibronectin to collagenous proteins. Mol. Cell. Biochem. 1984, 58:63-68.
46. Mosher D.F., Schad P.E., Vann J.M. Cross-linking of collagen and fibronectin by factor XIIIa. Localization of participating glutaminyl residues to a tryptic fragment of fibronectin. J. Biol. Chem. 1980, 255:1181-1188.
47. Muragaki Y., Kimura T., Ninomiya Y., Olsen B.R. The complete primary structure of two distinct forms of human alpha 1 (IX) collagen chains. Eur. J. Biochem. 1990, 192:703-708.
48. Mutolo M.J., Morris K.J., Leir S.H., Caffrey T.C., Lewandowska M.A., Hollingsworth M.A., Harris A. Tumor suppression by collagen XV is independent of the restin domain. Matrix Biol. 2012, 31:285-289.
49. Myers J.C., Yang H., D'Ippolito J.A., Presente A., Miller M.K., Dion A.S. The triple-helical region of human type XIX collagen consists of multiple collagenous subdomains and exhibits limited sequence homology to alpha 1(XVI). J. Biol. Chem. 1994, 269:18549-18557.
50. Myers J.C., Li D., Rubinstein N.A., Clark C.C. Up-regulation of type XIX collagen in rhabdomyosarcoma cells accompanies myogenic differentiation. Exp. Cell Res. 1999, 253:587-598.
51. Myllyharju J., Kivirikko K.I. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 2004, 20:33-43.
52. Nestle F.O., Zheng X.G., Thompson C.B., Turka L.A., Nickoloff B.J. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 1993, 151:6535-6545.
53. Nickoloff B.J. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch. Dermatol. 1991, 127:523-529.
54. Ninomiya Y., van der R.M., Mayne R., Lozano G., Olsen B.R. Construction and characterization of cDNA encoding the alpha 2 chain of chicken type IX collagen. Biochemistry 1985, 24:4223-4229.
55. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
56. Pan T.C., Zhang R.Z., Mattei M.G., Timpl R., Chu M.L. Cloning and chromosomal location of human alpha 1(XVI) collagen. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:6565-6569.
57. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
58. Paszek M.J., Weaver V.M. The tension mounts: mechanics meets morphogenesis and malignancy. J. Mammary Gland Biol. Neoplasia 2004, 9:325-342.
59. Provenzano P.P., Eliceiri K.W., Campbell J.M., Inman D.R., White J.G., Keely P.J. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006, 4:38.
60. Pucilowska J.B., Williams K.L., Lund P.K. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G653-G659.
61. Raghunath M., Unsold C., Kubitscheck U., Bruckner-Tuderman L., Peters R., Meuli M. The cutaneous microfibrillar apparatus contains latent transforming growth factor-beta binding protein-1 (LTBP-1) and is a repository for latent TGF-beta1. J. Invest. Dermatol. 1998, 111:559-564.
62. Ramchandran R., Dhanabal M., Volk R., Waterman M.J., Segal M., Lu H., Knebelmann B., Sukhatme V.P. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 1999, 255:735-739.
63. Ratzinger S., Eble J.A., Pasoldt A., Opolka A., Rogler G., Grifka J., Grassel S. Collagen XVI induces formation of focal contacts on intestinal myofibroblasts isolated from the normal and inflamed intestinal tract. Matrix Biol. 2010, 29:177-193.
64. Ratzinger S., Grassel S., Dowejko A., Reichert T.E., Bauer R.J. Induction of type XVI collagen expression facilitates proliferation of oral cancer cells. Matrix Biol. 2011, 30:118-125.
65. Ricard-Blum S. The collagen family. Cold Spring Harb. Perspect. Biol. 2011, 3:a004978.
66. Ricard-Blum S., Ballut L. Matricryptins derived from collagens and proteoglycans. Front. Biosci. 2011, 16:674-697.
67. Ricard-Blum S., Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol. Biol. (Paris) 2005, 53:430-442.
68. Rosenbloom J., Abrams W.R., Mecham R. Extracellular matrix 4: the elastic fiber. FASEB J. 1993, 7:1208-1218.
69. Sakai L.Y., Keene D.R., Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 1986, 103:2499-2509.
70. Schlotzer-Schrehardt U., Dietrich T., Saito K., Sorokin L., Sasaki T., Paulsson M., Kruse F.E. Characterization of extracellular matrix components in the limbal epithelial stem cell compartment. Exp. Eye Res. 2007, 85:845-860.
71. Schmidt A., Lorkowski S., Seidler D., Breithardt G., Buddecke E. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC. Eur. J. Clin. Invest. 2006, 36:473-482.
72. Schwarzbauer J.E., Patel R.S., Fonda D., Hynes R.O. Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J. 1987, 6:2573-2580.
73. Senner V., Ratzinger S., Mertsch S., Grassel S., Paulus W. Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion. FEBS Lett. 2008, 582:3293-3300.
74. Shanahan F. Crohn's disease. Lancet 2002, 359:62-69.
75. Sironen R.K., Karjalainen H.M., Torronen K., Elo M.A., Kaarniranta K., Takigawa M., Helminen H.J., Lammi M.J. High pressure effects on cellular expression profile and mRNA stability. A cDNA array analysis. Biorheology 2002, 39:111-117.
76. Tajima S., Akagi A., Tanaka N., Ishibashi A., Kawada A., Yamaguchi N. Expression of type XVI collagen in cultured skin fibroblasts is related to cell growth arrest. FEBS Lett. 2000, 469:1-4.
77. Tierney E.P., Tulac S., Huang S.T., Giudice L.C. Activation of the protein kinase A pathway in human endometrial stromal cells reveals sequential categorical gene regulation. Physiol. Genomics 2003, 16:47-66.
78. Tillet E., Mann K., Nischt R., Pan T.C., Chu M.L., Timpl R. Recombinant analysis of human alpha 1 (XVI) collagen. Evidence for processing of the N-terminal globular domain. Eur. J. Biochem. 1995, 228:160-168.
79. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
80. Toubal A., Ramont L., Terryn C., Brassart-Pasco S., Patigny D., Sapi J., Monboisse J.C., Maquart F.X. The NC1 domain of type XIX collagen inhibits melanoma cell migration. Eur. J. Dermatol. 2010, 20:712-718.
81. van der Rest M., Garrone R. Collagen family of proteins. FASEB J. 1991, 5:2814-2823.
82. Vogelaar C.F., Hoekman M.F., Gispen W.H., Burbach J.P. Homeobox gene expression in adult dorsal root ganglia during sciatic nerve regeneration: is regeneration a recapitulation of development?. Eur. J. Pharmacol. 2003, 480(1-3):233-250.
83. Wu J.J., Woods P.E., Eyre D.R. Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. J. Biol. Chem. 1992, 267:23007-23014.
84. Yamagata M., Yamada K.M., Yamada S.S., Shinomura T., Tanaka H., Nishida Y., Obara M., Kimata K. The complete primary structure of type XII collagen shows a chimeric molecule with reiterated fibronectin type III motifs, von Willebrand factor A motifs, a domain homologous to a noncollagenous region of type IX collagen, and short collagenous domains with an Arg-Gly-Asp site. J. Cell Biol. 1991, 115:209-221.
85. Yamaguchi N., Kimura S., McBride O.W., Hori H., Yamada Y., Kanamori T., Yamakoshi H., Nagai Y. Molecular cloning and partial characterization of a novel collagen chain, alpha 1(XVI), consisting of repetitive collagenous domains and cysteine-containing non-collagenous segments. J. Biochem. (Tokyo) 1992, 112:856-863.
86. Ziober A.F., Falls E.M., Ziober B.L. The extracellular matrix in oral squamous cell carcinoma: friend or foe?. Head Neck 2006, 28:740-749.